Author

Rodolfo Blanco‐Rodríguez

University of IdahoORCID 0000-0003-2972-2958Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:bacteria (other)· 1 Research Focus:benchmarking· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Esteban Abelardo Hernandez-VargasiD· 2 shared Alejandro AndersoniD· 1 shared Alejandro H. GonzáleziD· 1 shared Klas I. UdekwuiD· 1 shared Matthew W. Kinahan· 1 shared Tanya A. MiuraiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 11 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSystems Biology

Esteban Abelardo Hernandez-VargasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Systems BiologyPLoS Computational BiologyPeer-reviewedNov 20, 2025

CrossLabFit: A Novel Framework for Integrating Qualitative and Quantitative Data Across Multiple Labs for Model Calibration

Rodolfo Blanco‐Rodríguez, Tanya A. Miura, Esteban Abelardo Hernandez-Vargas

CrossLabFit integrates qualitative and quantitative data from multiple labs to improve model calibration and accuracy through machine learning and GPU-accelerated optimization.

2 citations

machine learning (classical)benchmarking

𝕏 PostBluesky

Evolutionary BiologybioRxivPreprintFeb 16, 2025

Computational Platform for streamlining the success of sequential antibiotic therapy

Alejandro Anderson, Matthew W. Kinahan, Rodolfo Blanco‐Rodríguez…·Esteban Abelardo Hernandez-Vargas

The paper develops an open-source computational platform to predict failures of sequential antibiotic therapy using collateral sensitivity and bacterial resistance profiles.

DOI 10.1101/2025.02.16.638553

bacteria (other)proteomics

𝕏 PostBluesky